Ignite Creation Date:
2025-12-24 @ 10:22 PM
Ignite Modification Date:
2026-03-01 @ 8:59 PM
Study NCT ID:
NCT06613035
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-09-25
First Post:
2024-09-22
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Twice-per-weekSelinexor, 2 Days Melphalan
Sponsor:
Institute of Hematology & Blood Diseases Hospital, China
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
IIT2024062
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None